Gaetani, Lorenzo http://orcid.org/0000-0003-3967-8954
Salvadori, Nicola
Lisetti, Viviana
Eusebi, Paolo
Mancini, Andrea
Gentili, Lucia
Borrelli, Angela
Portaccio, Emilio
Sarchielli, Paola
Blennow, Kaj
Zetterberg, Henrik
Parnetti, Lucilla
Calabresi, Paolo
Di Filippo, Massimiliano
Article History
Received: 25 March 2019
Revised: 20 May 2019
Accepted: 22 May 2019
First Online: 25 May 2019
Compliance with ethical standards
:
: LGa participated on advisory boards for and received speaker or writing honoraria and funding for travelling from Almirall, Biogen, Biogen-Idec, Genzyme, Mylan, Novartis, Roche, Teva. AM received travel grants from Teva and Sanofi Genzyme to attend national conferences. PC received/receive research support from Bayer Schering, Biogen-Dompé, Boehringer Ingelheim, Eisai, Lundbeck, Merck-Serono, Novartis, Sanofi-Aventis, Sigma-Tau, and UCB Pharma. KB has served as a consultant or at advisory boards for Alzheon, BioArctic, Biogen, Eli Lilly, Fujirebio Europe, IBL International, Pfizer, and Roche Diagnostics, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. HZ has served at advisory boards for Eli Lilly, Roche Diagnostics and Pharmasum Therapeutics and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. MDF participated on advisory boards for and received speaker or writing honoraria and funding for travelling from Bayer, Biogen Idec, Genzyme, Merck, Novartis, Roche and Teva. NS, VL, PE, LGe AB, EP, PS and LP report no conflict of interest.
: The study was approved by the local ethics committee.